TEL AVIV, Israel, Aug. 19, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), today announced that DeepSolar, PainReform’s solar energy business unit developing next-generation AI-driven solar ...

The two-week span between September 7 and September 21, the window between the lunar eclipse in Pisces and the solar eclipse ...

The full moon on Sept. 7, 2025 will be a "blood moon" total lunar eclipse. Here's who will see the longest total lunar ...

The Valley Industry Association announced two new expansions to its signature Connecting to Success program, which is designed to reflect the organization’s continued commitment to inclusive education ...

Covid was a tough time for many small businesses, but these two Riverina Murray businesses say their “lifeline” will be cut by a recent State Government decision. The $10m Business Connect program – a ...

NSW Premier Chris Minns speaks to the media during a press conference at NSW Parliament, Sydney, Wednesday, August 6, 2025. Source: AAP Image/Bianca De Marchi New South Wales Premier Chris Minns has ...

The Illinois Family Roots Pilot program is expanding across the state after launching in June with 250 kits. A program aimed at helping Black residents trace their ancestry, and in some cases, ...

A nonprofit program that helps people from underrepresented backgrounds get ahead in commercial real estate is expanding to help professional athletes, with a base in Boston. One of Boston's largest ...

The number of unhoused people is growing every day, and the City of Williamsburg says it's taking a new approach to meet people where they are. The HOPE Team Program is taking a boots-on-the-ground ...

I’ve been writing and editing technology articles for more than seven years, most recently as part of PCMag's software team. I am responsible for content in the AI, financial, graphic design, ...

The total lunar eclipse on Sept. 7, 2025, will be the longest since 2022. Here’s where to stream it live on YouTube.

Overview: Black Diamond Therapeutics, Inc. is a clinical-stage oncology company dedicated to developing MasterKey therapies for genetically defined tumors, with a market cap of $157.14 million.